Epoch Biodesign has signed a new lease at Pembroke’s 10 Finsbury Square, EC2.
The company, which specialises in synthetic biology, will occupy 12,150 sq ft of workspace, known as the Green Room. It was recently redesigned to offer adaptable studio and lab space and end-of-trip facilities.
Epoch plans to use the space to expand its protein engineering platform, grow its R&D team and scale its first process to transform plastic waste.
Sandra Cooper, director of asset management at Pembroke, said: “The strong environmental and wellbeing credentials of 10 Finsbury Square were fundamental to securing an innovative occupier like Epoch, offering the space and facilities that support a growing business.”
Jade Dedman, associate at Savills who advised Pembroke on the deal, added: “The Covid-19 pandemic has shone a spotlight on the strength and depth of the UK’s science market, which continues to develop. In central London we are seeing ever more appetite for space from life science players, for both traditional office space and more bespoke labs.”
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
View other office deals in EC2 >>
See which agents are the most active in the London submarkets >>
